Buy One Get One free -Llimited Time Offer X
Prexaron 2 ml Injection is a commercial drug that is prescribed in the form of Injection. Stroke are some of its major therapeutic uses. Prexaron 2 ml Injection also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Prexaron 2 ml Injection. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Prexaron 2 ml Injection also has some side effects, the most common being Headache, Blurred vision, Increased blood pressure. Apart from the aforementioned side effects, Prexaron 2 ml Injection can also lead to other problems, which have been listed below. Normally, these side effects of Prexaron 2 ml Injection are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Prexaron 2 ml Injection's effect during pregnancy is Unknown and Unknown while nursing. In addition, Prexaron 2 ml Injection's effects on the liver, heart and kidney are discussed below in the Prexaron 2 ml Injection related warnings section.
The section on Prexaron 2 ml Injection contraindications lists all such conditions.
Drug interactions for Prexaron 2 ml Injection have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Prexaron 2 ml Injection is not safe while driving, and is is not addictive in nature.
Prexaron 2 ml Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Prexaron 2 ml Injection safe for pregnant women?
Side effects of Prexaron during pregnancy are not known because scientific research on this topic hasn't been done.
Is the use of Prexaron 2 ml Injection safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Prexaron for breastfeeding women are not known.
What is the effect of Prexaron 2 ml Injection on the Kidneys?
In the absence of any scientific study on the side effects of Prexaron on kidney, information on safety of Prexaron for kidney is unavailable.
What is the effect of Prexaron 2 ml Injection on the Liver?
So far, no research has been carried out on the effects of Prexaron on the liver. So it is not known whether taking Prexaron will affect the liver or not.
What is the effect of Prexaron 2 ml Injection on the Heart?
No research work has been carried out till date on effects of Prexaron on heart. So it is not known whether taking Prexaron will cause side effects on heart or not.
If you are suffering from any of the following diseases, you should not take Prexaron 2 ml Injection unless your doctor advises you to do so -
Is this Prexaron 2 ml Injection habit forming or addictive?
Prexaron 2 ml Injection does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Prexaron 2 ml Injection. So it is best to avoid driving.
Is it safe?
Prexaron 2 ml Injection is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Yes, Prexaron 2 ml Injection is useful in treating mental disorders.
Interaction between Food and Prexaron 2 ml Injection
You can take Prexaron 2 ml Injection with food.
Interaction between Alcohol and Prexaron 2 ml Injection
No research has been done on this till date. Therefore, it is not known what the effect of taking Prexaron 2 ml Injection with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 491